Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Japanese”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00736788
What this trial is testing

Assess Safety, Tolerability and Pharmacokinetic (PK) of AZD1704 in Healthy Japanese Male and Non-Fertile Female Volunteers

Who this might be right for
Healthy Volunteers
AstraZeneca 16
Early research (Phase 1)Study completedNCT05519540
What this trial is testing

PK Study of Xevinapant (Debio 1143) in Healthy East Asian Participants

Who this might be right for
Healthy
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 24
Early research (Phase 1)Study completedNCT01341470
What this trial is testing

LY2495655 in Healthy Subjects

Who this might be right for
Healthy Volunteer
Eli Lilly and Company 47
Early research (Phase 1)Study completedNCT06125366
What this trial is testing

Learn More About the Safety and the Level of BAY 1747846 in Body Given as Injection Into the Vein at Increasing Single Doses in Japanese Healthy Male Participants

Who this might be right for
Contrast Enhancement in Magnetic Resonance ImagingHealthy Volunteers
Bayer 25
Early research (Phase 1)Study completedNCT02028780
What this trial is testing

Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 (Idarucizumab) Administered Alone or With Dabigatran Etexilate in Japanese Healthy Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 80
Early research (Phase 1)Study completedNCT03736772
What this trial is testing

LY3090106 in Japanese and Caucasian Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 30
Early research (Phase 1)Study completedNCT04394845
What this trial is testing

The Biodistribution and Safety of [18F]GTP1 in Healthy Japanese Participants

Who this might be right for
Alzheimer Disease
Genentech, Inc. 6
Large-scale testing (Phase 3)Study completedNCT02492165
What this trial is testing

Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects

Who this might be right for
Japanese Encephalitis
Sanofi Pasteur, a Sanofi Company 250
Early research (Phase 1)Study completedNCT00970775
What this trial is testing

AZD2423 Single Ascending Dose Study in Healthy Japanese Subjects

Who this might be right for
Healthy Volunteer
AstraZeneca 32
Early research (Phase 1)Study completedNCT03399734
What this trial is testing

Bioequivalence Study Between a 4-mg Dose of Fine Granules of Perampanel and a 4-mg Tablet of Perampanel in Healthy Japanese Subjects

Who this might be right for
Healthy Participants
Eisai Co., Ltd. 24
Early research (Phase 1)Study completedNCT00448032
What this trial is testing

Study Evaluating Multiple Oral Doses of PPM-204 in Healthy Japanese Male Subjects

Who this might be right for
Diabetes Mellitus
Wyeth is now a wholly owned subsidiary of Pfizer
Early research (Phase 1)Study completedNCT01375387
What this trial is testing

Three-way-cross-over Study to Evaluate Safety and Pharmacokinetics of Lacosamide in Healthy Japanese and Chinese Males

Who this might be right for
Healthy Volunteers
UCB Pharma 33
Early research (Phase 1)WithdrawnNCT02322606
What this trial is testing

A Phase 1, Single and Multiple Dose Study of TAK-137

Who this might be right for
Healthy Japanese Adult Male
Takeda
Early research (Phase 1)Study completedNCT01894399
What this trial is testing

Study to Evaluate a Pharmacokinetic of HM61713 in Healthy Male Subjects

Who this might be right for
Healthy Volunteers
Hanmi Pharmaceutical Company Limited 59
Post-approval studies (Phase 4)Study completedNCT01635816
What this trial is testing

Immunogenicity of SA 14-14-2 JE Vaccine

Who this might be right for
Healthy Infants
International Centre for Diarrhoeal Disease Research, Bangladesh 1,000
Early research (Phase 1)Study completedNCT06453551
What this trial is testing

A Phase I Study of TRN501 in Healthy Volunteers

Who this might be right for
Parkinson Disease
SNLD, Ltd. 72
Early research (Phase 1)Study completedNCT01081821
What this trial is testing

Single and Multiple Dose Study to Explore the Safety and Pharmacokinetics of JNJ-39758979 In Healthy Male Volunteers of Either Caucasian or Japanese Descent

Who this might be right for
Healthy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 61
Early research (Phase 1)Study completedNCT01655056
What this trial is testing

Evaluate the Safety and Tolerability of YM150 in Healthy Caucasian and Japanese Male and Female Subjects, and to Assess the Effect That Gender May Have on Its Actions in the Body

Who this might be right for
PharmacokineticsPharmacodynamicsHealthy Subjects+2 more
Astellas Pharma Europe B.V. 82
Early research (Phase 1)Study completedNCT00434187
What this trial is testing

Study to Evaluate Multiple Doses of ERB-041 in Healthy, Female Japanese Subjects

Who this might be right for
Healthy
Wyeth is now a wholly owned subsidiary of Pfizer 24
Early research (Phase 1)Study completedNCT00752544
What this trial is testing

TMC435350-TiDP16-C109: A Safety Study for TMC435350 in an Oral Solution Containing Either 100, 200 or 400 mg Equivalent of TMC435350 or Placebo in Healthy Japanese Male Volunteers

Who this might be right for
HCV
Tibotec Pharmaceuticals, Ireland 30
Next Page